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Abstract
Background: With age, the human lens accumulates variety of substances that absorbs and
fluorescence, which explains the color of yellow, brunescent and nigrescent cataract in terms of aging.
The aim of this study was to assess lens fluorophores with properties comparable to those of
advanced glycated end products (AGEs) in relation to age in human lenses. These fluorescent
compounds are believed to be involved in the development of cataract.
Methods: Spectroscopic (UV-Vis-NIR) and fluorescence photography (CCD-Digital based image
analysis) studies were carried out in randomly selected intact human lenses (2–85 years). AGE-like
fluorophores were also measured in water soluble and insoluble (alkali soluble) fractions of human
lenses (20–80 years).
Results: Our experimental findings suggest that there was a progressive shift in the absorbance
characteristic of intact lens in the range of λ210 nm-λ470 nm. A relative increase in the absorptivity at
λ(511–520 nm), with age, was also observed. In addition, the ratio of absorptivity at λ(511–520 nm) versus
the maximum absorbance recorded at blue-end cut-off (210–470 nm) was also found to increase,
with age. The fluorescent intensity in the intact lens at both UV-B (λEx312 nm) and UV-A (λEx365 nm)
were found to be positively correlated (r2 = 0.91 & 0.94, respectively; Confidence interval 95%)
upto 50 years of age. In addition, a concomitant changes in AGE- like fluorophores were also
observed in the processed lens samples (soluble and insoluble fractions) along the age. A significant
increase in the concentration of AGE- like fluorophores, both in intact and processed lens was
observed during the period of 40 – 50 years.
Conclusion: Based on the present investigation, it was concluded that significant changes do occur
in the AGE-like fluorophores of human lenses during the period of 40–50 years.
Background
The young human lens is colorless and transmits almost
100% of the incident light. With age, photochemical
mediated interactions results in the development of color-
ation of lenses and formation of fluorescent biochemical
products [1]. Light mediated damage to the lens proteins
can only occur due to the presence of light absorbing
chromospheres. It has been reported earlier that the
young lenses shows higher absorbance at 280 nm due to
the presence of aromatic amino acids like tryptophan and
tyrosine constituent of crystallins [2]. During the process
of aging, the human lenses become progressively more
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yellow and fluorescent [3-5]. The age-related increase in
lens coloration and fluorescence is associated with the
major proteins of the lens, the crystallins, which are par-
ticularly prominent in the lens nucleus [4,5]. The lens pro-
teins are as old as the individual since there is little or no
turn over of these proteins [6]. Numerous chemical and
photochemical processes may account for these changes,
which include the (i) photochemical modification of
tryptophan [7] (ii) lipid peroxidation [8] and (iii) chemi-
cal linking of sugar or ascorbic acid through the Maillard
reaction [9,10].
The Maillard reaction, a non-enzymatic reaction between
ketones or aldehydes and primary amino groups of mac-
romolecules, contributes to the aging of proteins and to
complications associated with diabetes [11-13]. Advanced
glycated end products (AGEs) were originally character-
ized by a yellow-brown fluorescent color and their ability
to form cross-links with and between amino groups [14].
Fluorescence is one of the qualitative properties classically
used to estimate AGE formation in addition to their
brown coloration. There is considerable evidence that
AGE of lens proteins are involved in browning and fluor-
ophore formation in the lens [15,16]. Several different
AGEs (fluorescent cross-links and non-fluorescent cross
links) have been detected in the human lenses, mainly by
immunochemical methods using both polyclonal and
monoclonal antibodies [17-21] in normal, aged and cata-
ractous lenses. The identified fluorescent AGEs species in
lens include pentosidine[22], pyralline[24], crossal-
ine[23], vesperlysine, and argpyrimidine[24]. Addition-
ally, Franke et al., [17] have reported the presence of
pentosidine and imidazolone, in cataractous lenses.
Methylglyoxal-derrived hyroimidiazolone AGEs are the
major glycation adducts found in lens proteins compare
to argpyrimidine and pentosidine [25]. Undoubtedly,
there are a number of AGE-like fluorophore that are
formed in human lenses during the course of aging. The
direct relationship between the amount of AGEs and
increased yellowing of lens was reported earlier by Das et
al., [26] using synchronous fluorescence (SF) method. The
SF spectra of human lens sample closely resembled those
of in vitro AGEs derived from incubation of BSA with glu-
cose.
In addition, post-translational modifications by kynure-
nine (tryptophan-metabolite), 3-hydroxykynurenine glu-
coside (3-OHKG) with lens crystallins [27-29] as aging
fluorophores, have been considered as biomarker for
aging of lens. However, no spectroscopic studies have
been carried out on the aging of human lenses, which par-
ticularly deals with the early onset of cataractogenesis in
terms of AGE-like fluorophores formation, which can be
correlated with biochemical and photo-biological events
occurring during our lifetime.
The present experimental investigation was designed to
assess AGE-like fluorophores with properties comparable
to those of advanced glycated end products (AGEs) in
relation to age in human lenses by spectroscopic
approach. This study was undertaken to address the early
onset of cataractogenesis in terms of AGE-like fluoro-
phore formation in human lens.
Table 1
Age group (years) Number lenses (n)
22
15–17 5
20–23 5
30–35 5
45–47 5
57–60 5
65–70 3
75 – 85 15
Table 2: Relative change in the ratio of absorbance observed in the region of 511–520 nm versus absorbance recorded at blue-end cut-
off region.
Age of lens (year) Absorbance# in the region of λ511–520 nm Ratio of Absorbance# Absorbance at λ511–520 nm λmax at blue-end cut-off
2 0.25 0.25/1.5 = 0.16
15 0.6 0.6/3.12 = 0.192
20 1.0 1.0/3.5 = 0.28
30 1.2 1.2/3.8 = 0.315
45 1.3 1.3/4= 0.325
60 1.35 1.35/> 4*
65 2.6 2.6/> 4*
75 1.18 1.18/3.5 = 2.96
80 2.3 2.3/> 4*
85 2.75 2.75/> 4*
# Mean value
* Values not calculated as absorbance was > 4.0BMC Ophthalmology 2006, 6:10 http://www.biomedcentral.com/1471-2415/6/10
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Methods
Human lenses (2–85 years) were obtained from
Ramayamma International Eye Bank (Member of the
International Federation of Eye Banks & Eye Bank Associ-
ation of India)L V Prasad Eye Institute, Hyderabad, India.
This study was undertaken with the approval of the ethics
committee of L V Prasad Eye Institute, Hyderabad, India.
The informed consent was also obtained for collecting
those cadaver lenses through the Eye Bank of L V Prasad.
They were stored at -80°C, until further use.
Chemicals
Bovine serum albumin {(BSA) Essential fatty acid & glob-
ulin free}, Glucose (Dextrose; corn sugar), L-arginine were
purchased from Sigma Chem. Co. St. Louis, USA. Crystal-
line D- ribose from Hi Media, India. Amino acids, L-tyro-
sine and L-histidine were from Eastman Kodak Company,
Rochester, N.Y and L-lysine monohydrochloride from M/
s Sarabhai M. Chemicals, Baroda, India. All other reagents
used were of analytical grade.
Spectral measurements
Human lenses (2–85 years, n = 45) with varying degree of
yellow- brown coloration were randomly selected for the
spectral analysis and grouped as shown in Table 1.
Intact lenses were subjected to fiber optic based digital
UV-Vis-NIR spectrophotometer (Ocean Optics, Nether-
lands) analysis. This system uses the continuous output of
Xenon lamp (200–1000 nm) and is based on 1024 diode
array detector system. This detector is capable of collecting
full wavelength spectra with good signal to noise ratio at
an integration on time of 1 milli sec. The excitation light
is led into the sample chamber through a fiber optic bun-
dle, and the transmitted light is then collected by a second
fiber optic bundle positioned at an angle of 180° to the
excitation source. The excitation and transmitted light are
collimated by a set of focusing lens on the either side of
the sample chamber. The spectra from the intact human
lenses were taken against the dark (0% transmittance) and
reference (100%T) spectra. The acquired digital data was
analyzed using the software (OOI, Basic Acquisition Soft-
ware, Version 1.52.) supplied along with the instrument.
Fluorescence studies
Forty lenses (20–80 years) were selected for fluorescent
studies. Fluorescent intensity (density) in the intact
human lenses were measured peak volume at both UV-B
and UV-A (λEx312 nm & λEx365 nm,) respectively with an emis-
sion in the range of 380 nm to 470 nm, using highly sen-
sitive charged coupled device (CCD) based digital image
analyzer (UVItec) Cambridge, U.K. Volume of the digital
image due to fluorescent intensity (density) was analyzed
by using UVI Image Acquisition and Analysis Software.
Digital Image Analysis System
This system consists of a high-resolution CCD-based
(charged coupled device) camera (monochrome type)
with absorbance and fluorescence facility. The CCD-cam-
era has an optical zoom lens (12.5 × 75 mm/f1.8) along
with 49-mm+1 dioptres close-up lens. The sensitivity of
the camera is 10-5 lux, with negligible signal to noise ratio
(< 30 db). The CCD camera is housed in a light-tight com-
pact cabinet over a trans-illuminator. The camera is
equipped with UV & IR interference filter. The acquired
image is displayed on an in-built LCD screen (resolution
– 8 bit, 256 gray level images). The image acquisition is
base on real time integration in the range of 0.04 to 10
seconds. The image acquisition system is linked to Intel
Pentium 4 processor base computer, loaded with UVi-tech
image processing and store software (64-bit data soft-
ware). The digitized image has a resolution of 752(H) ×
582 (V) pixels. The trans-illuminator consists of dual
wavelength (312 and 365 nm) UV lamps with out put
light intensities of 8 mW/cm2.
The digital image acquisition was achieved by placing the
intact lens on flat surface of the trans-illuminator, housed
in the light-tight cabinet. For florescence studied, the sam-
ple was excited individually from the base at both UV-B &
UV-A (λEx312 nm & λEx365 nm) region of the electromagnetic
spectrum. Lens image formed due to the emission (range
380 nm to 470 nm) was acquired by real time integration
at 0.2 seconds for 312 nm and 0.04 seconds for 365 nm.
Annotated images were saved in PC compatible file for-
mat (tiff file) in a floppy. Later, the digital images of the
intact lens were analyzed by the software for determining
the net fluorescence intensity (density), which was meas-
ured as peak volume.
Processing of human lens samples
Lenses (20–80 years) were homogenized individually in
20 mM Phosphate buffer pH 7.4 (10% w/v), centrifuged
at 10,000 × g for 30 min at 4°C, and separated into super-
natant and precipitate. The supernatant referred to as the
"water soluble" fraction and precipitate as the "water
insoluble" fraction. An aliquot of the insoluble protein
(1–3 mg) was solublized in 200–500 µL of 0.1 N NaOH.
Both fractions were used for fluorescent studies for the
estimation of AGE-like fluorophores. Protein was esti-
mated by the method of Lowry et al., [30] using BSA as ref-
erence standard. For fluorescent studied 1 mg/mL of
protein was taken.
Chemical synthesis of AGE-like fluorophores
Synthetic AGE-like fluorophores were prepared for com-
parison with lens AGE-like fluorophores [31].
(i) BSA (1 mg/mL of 0.1 N NaOH) was used as control
blank for fluorescent studies. (ii) BSA-AGE was preparedBMC Ophthalmology 2006, 6:10 http://www.biomedcentral.com/1471-2415/6/10
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by modified method of Nakagawat, et al., [31]. It was pre-
pared by incubating 1.5 µ mole BSA with 1.6 mmole glu-
cose, 0.7 mmole ribose in 5 mL of 0.4 M phosphate
buffer, pH 7.4. The samples were processed under sterile
condition using the Laminar flow hood. The vials were
sealed and placed in an air-circulating incubator, at 37°C
for 10 weeks. After incubation, mixture was dialyzed and
concentrated using spin column (Ultrafree-MC filters,
molecular weight cut-off limit – 10 kDa, Sigma Chem. Co.
St. Louis, USA.). The degree of glycation was checked by
trinitobenzene sulfonic acid method [32]:
(iii) Chemical synthesis of amino acids mixture -AGE:
Here we have selected few protein amino acids, which are
present in the sequence of human γ-crystallins. These
amino acids were selected because of their high suscepti-
bility to glycation/AGE formation in the course of cataract
development. To mimic the fluorescent AGEs like
crosslinks (pentosidine, argpyrimidine, pentosidine,
pyropyridine etc.), we incubated following amino acids
mixture: 9.5 µ mole of lysine, 100 µ mole of arginine, 23
µ mole histidine and 67 µ mole of tyrosine along with 1.6
mmole glucose, 0.7 mmole ribose in 5 mL of 0.4 M phos-
phate buffer, pH 7.4 under the same experimental condi-
tions as mentioned above. A "zero" day sample of above
mentioned amino acid mixture with sugars was used as
control blank.
Fluorescence measurements
Fluorescent measurements were performed in total as well
as both fractions of human lens samples, using a spec-
trofluorimeter (Perkin-Elmer, LS-3B, Norwalk, NJ, USA).
AGE-like fluorophores were measured as described earlier
[33] in sample, experimentally synthesized AGE-like
fluorophores as well as in control blank (BSA /1 mg/mL
in 0.1 N NaOH). These AGE-like fluorophores were meas-
ured at their respective excitation and emission wave-
length, in the following order:
AGE (λEx347 nm/λEm415 nm); pentosidine (λEx335 nm/λEm385
nm); pentodilysine (λEx366 nm/λEm440 nm); crossline (λEx379
nm /λEm463 nm); pyropridine(λEx370 nm /λEm455 nm); argpyri-
midine(λEx320 nm/λEm382 nm). Results are expressed as fluo-
rescence intensity/mg of lens protein.
Statistical analysis
The data was statistically analyzed by using Sigma-plot
software version 5.0. The test of significance was based on
Student's t- test.
Results
The absorption spectra of intact human lenses from vari-
ous age groups (2–85 years) are given in Figure 1. There
was a progressive shift of absorbance in the region of λ210-
λ470 nm, in relation to age (exception 75 year old lens).
Table 2 clearly indicates a relative increase in the absorp-
tivity at λ(511–520 nm), with age. The ratio of absorptivity at
λ(511–520 nm) versus the maximum absorbance recorded at
blue-end cut-off (210–470 nm) was also found to
increase, with age.
The Digital image analysis of the intact lens (20 and 60
years) is depicted in figure 2. A significant increase in the
net fluorescence intensity was observed in the 60-year-old
lens as compared to 20-year-old lens, which was used as a
control. Figure 3, 4 depicts the net fluorescence intensity
recorded in the intact lenses at λEx312 nm and λEx365 nm from
the different age groups. The fluorescence intensity (den-
sity) in the intact lenses shows an increasing trend up to
the age of 50 years (r2 = 0.9 at λEx312 nm and r2 = 0.94 at
λEx365 nm; Confidence interval 95%). There was a statisti-
%
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A typical superimposed representative absorption spectrum  of intact human lenses (2–85 years) Figure 1
A typical superimposed representative absorption spectrum 
of intact human lenses (2–85 years). a- 02, b- 15, c- 20, d- 30, 
e- 45, f- 60, g- 65 (diabetic), h- 75, i- 80, j-85 years old lenses. 
A progressive shift in the wavelength of absorption from λ210 
nm to λ470 nm was observed. An increase in absorbance was 
recorded (range 0.25 to = 3.0 - not shown on y - axis) at λ511–
520 nm with age.
A 511-520 nm A 511-520 nmBMC Ophthalmology 2006, 6:10 http://www.biomedcentral.com/1471-2415/6/10
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cally significant (p < 0.001) increase in fluorescence inten-
sity (density) at λEx312 nm as compared to λEx365 nm for all
age groups (figure 5). The quantitative estimation of AGE-
like fluorophores is shown in Figure 6a, b, c and 6d for the
processed lens samples and Figure 7a & b for in vitro syn-
thesized AGE-like fluorophores. Distribution of AGE- like
fluorophores show a similar trend in processed lens sam-
ples as well as in vitro synthesized AGE-like fluorophores
(figure 6 &7). There was a 2.5 fold increase in fluorescence
intensity at 40 years as compare to 20-year-old lenses,
with an increasing trend up to 60 years in total lens
homogenate (figure 6a &6b). Similar changes were also
observed in soluble/insoluble protein fractions of lenses.
A threefold difference in fluorescence intensity was
observed at the age of 60 years as compare to 20 year old
human lenses (figure 6c &6d).
Chemically, BSA-AGE and amino acid based AGE was suc-
cessfully synthesized and tested by fluorimetric analysis.
The degree of BSA-glycation was monitored by TNBS assay
and was observed to be 86% at the end of 10 weeks of
incubation. The BSA-AGE and amino acid mixture-AGE
showed typical fluorescence similar to that of lens AGEs,
while the BSA and amino acid mixture control blank,
showed no fluorescence (figure 7a &7b).
Discussion
Earlier workers have reported the presence of light absorb-
ing chromophores formed during the course of cataract
development [1]. Young lenses show higher absorbance at
280 nm due to the presence of aromatic amino acids like
tryptophan and tyrosine constituents of crystallins [2].
Apart from this absorbance, the sensitive method of scan-
ning intact lenses, based on 1024 diode array detector sys-
tem, used by us indicates that the absorbance due to other
suspected aromatic amino acids like histidine (240 nm),
phenylalanine (254 nm) and sulphur containing amino
acid like cysteine (235 nm) [34] may also contribute to
the absorbance as observed in the present investigation
(figure 1). This process in turn ultimately affects the shift-
ing of wavelength from λ378 nm to λ470 nm in lenses from the
age of 45 years onwards, may be due to the formation of
AGE-like fluorophores. The direct relationship between
the amount of AGE-like fluorophores and increased yel-
lowing of lens was reported earlier by Das et al., [26] using
synchronous fluorescence (SF) method between wave-
lengths 340 – 480 nm. The spectral data obtained in the
present investigation suggests that there was an altered
absorptivity in the region of λ210-λ470 nm during the course
of aging. However, this interpretation is limited due to the
use of solid sample (intact lens) for analysis, wherein the
absorbency may reach a point of saturation at lower wave-
lengths (blue-end region of the spectra). Figure 1, depicts
a spectral shift from blue-end cut-off towards the red end
region of the spectrum, with age. Further, the ratio of the
absorbance observed at λ511–520 nm versus the maximum
absorbance recorded at blue-end cut-off indicates a pro-
gressive increase, with age (Table 2). As in younger lenses
the absorption was minimum at 511–520 nm and
Relationship between age (20–80 years) and fluorescence  intensity at λEx312 nm of intact human lenses, using digital  based image analysis. Figure 3
Relationship between age (20–80 years) and fluorescence 
intensity at λEx312 nm of intact human lenses, using digital 
based image analysis. (y -axis values in exponential; Values, 
mean ± S.E).
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Digital based photographic analysis of a typical intact human  lens (A)- 20 year (control) and (B) 60 year cataractous, at  λEx312 nm /λEm380–470 nm Figure 2
Digital based photographic analysis of a typical intact human 
lens (A)- 20 year (control) and (B) 60 year cataractous, at 
λEx312 nm /λ Em380–470nm. The fluorescence intensity (density) 
increased with age.
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because no significant change with age at longer wave-
length, we chose to use the red-end tail of the UV-absorp-
tion peak of the intact lens for calculating the ratio of
absorptivity at λ(511–520 nm) versus the maximum absorb-
ance recorded at blue-end cut-off (210–470 nm), during
the course of ageing. Possibly, these changes indirectly
reflect the AGE-like complex formation from the age of 45
year onwards (Table 2). Lerman and Borkman [4]
observed two-age related fluorescent compounds, which
develop in the lens nucleus. The first showed an excitation
at 340–360 nm with emission at 420–440 nm. The sec-
ond, which appeared to be a secondary product of the
former being detectable only after the first decade of life,
absorbing light at 415 nm–435 nm with emission at 500–
520 nm. It remained relatively at low level until the fourth
or fifth decade. The presence of a second type of fluoro-
phore as reported by Lerman & Borkman [4], which
remained at low level (absorbance value < 1.0) until the
third decade (age 30 years) of life. We observed no signif-
icant spectral changes below 20-year-old lenses, thus the
fluorescence studies were carried out on lenses from 20
years onwards.
It is contentious as to whether fluorescence studies are
true representative of absorption by specific fluorescent
compounds present, particularly in the aging lenses. Thus,
a study of intact lens, preserving all its condensed phase
features, would be of interest. To quantify this age related
changes, the fluorescence studies were carried out at two
wavelengths - λEx312 nm and λEx365 nm (figure 2,3,4). The
results obtained clearly demonstrate that as the human
lens ages, there were significant changes in the non-tryp-
tophan (or "blue) fluorescence [22] because both selected
wave length are for blue fluorophore compounds like arg-
pyrimidine[18] and pentodilysine[35]. There are
undoubtedly a number of post-translational modifica-
tions that occur in lenses with age. The change of AGE-
like fluorophore in lenses were found to increase until the
age of 50 years, there after, fluorescence begins to drop. A
probable explanation for this observation is that a
method of external fluorescence measurement on the
intact lens cannot follow the increasing concentration of
fluorophores because it is affected by increasing self
absorption (figure 3 & 4) at λEx312 nm and λEx365 nm, respec-
tively with age. These observations indirectly decipher the
characteristic trough observed at λ467–556 nm (figure 1) in
aging lenses. Previous studies have shown that lens auto-
fluorescence increases quantitatively with age [21,22] and
in diabetic condition [22]. The remarkable similarities
between diabetic and the non-diabetic lenses suggest that
the mechanisms of fluorophore formation are alike in
diabetic and non-diabetic condition. Increased glycation
of lens crystallins in senile and diabetic cataractous lenses
have been investigated by immunochemical and fluores-
cence studies [19,26]. These, findings indicate fluorescent
AGEs species including pentosidine [22], pyralline [24],
crossaline [23], vesperlysine, and argpyrimidine [24] in
lens. Undoubtedly, there are a number of AGE-like fluor-
ophore that are formed in human lenses during the course
of aging. The rate of change of λEx312 nm /λEx365 nm may be
considered to be a qualitative estimate of argpyrimidine
(λEx320 nm) and pentodilysine (λEx366 nm), which may
reflect their relative level during ageing. The level of argpy-
rimidine (λEx320 nm) was found to be significantly higher
than any other fluorophore (Figure 5). This inference has
been further supported by the observations of Kessel et al.,
Comparison of AGE-like fluorophores (at λEx312 nm and λEx365  nm) as a function of age in intact human lenses. Figure 5
Comparison of AGE-like fluorophores (at λEx312 nm and λEx365 
nm) as a function of age in intact human lenses. Increase in flu-
orescence intensity (p < 0.001; Confidence interval 95%) at 
λEx312 nm as compared to λEx365 nm. (y-axis values in exponen-
tial; Values, mean ± S.E).
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[22], $wherein they reported higher concentration of arg-
pyrimidine in cataractous lenses. It is pertinent to note
that the distribution of these fluorophores in processed
lens samples, did not show any distinct pattern at their
respective excitation (Figure 6b &6d). This suggests that
one of the dominating fluorophore or very closely related
Determination of AGE-like fluorophores in processed lens (total, soluble, & and insoluble) fractions from different age group  (20–80 years). Figure 6
Determination of AGE-like fluorophores in processed lens (total, soluble, & and insoluble) fractions from different age group 
(20–80 years). Values are mean of five determinations and their CV was < 8%. Fig. 6a shows AGE-like flurophores in the total 
lens homogenate. Fig. 6b depicts the profile of various AGEs in the total lens homogenate. Fig. 6c illustrates the AGE-like 
fluorophores as a ratio of soluble to insoluble fraction of lens homogenate. Fig. 6d represents the profile of various AGEs as a 
ratio of soluble to insoluble fraction of the lens homogenate.
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groups of fluorophores give rise to a typical pattern (Fig-
ure 6a &6c) of the fluorescence spectra in the processed
lens sample. Kessel et al., [22] observed a similar phenom-
enon. The changes in these fluorophores possibly com-
mences from 30 years of age and peaks at 60 years, when
total lens proteins are take into account (figure 6a); while
the trend is reversed when the ratio of soluble to insoluble
lens protein fraction is considered (figure 6c).
AGE-like fluorophore concentration is found to increase
in both total and insoluble fraction in the lens during the
period of 40 – 60 years. (Figure 6a &6c). This finding is
similar to the one reported earlier by Das et al., [26], using
synchronous fluorescence (SF) and immunochemical
methods. These observations suggest that AGE-like fluor-
ophores may contribute to protein insolubilizaton, which
ultimately leads to the coloration, opacity and catrac-
togenesis along with the age.
Our present fluorescent data of human lens samples
resemble those of chemically synthesized AGEs, derived
from incubation of BSA and amino acids mixture with
sugars (figure 7), may suggest that such fluorophores con-
tribute to the fluorescence of human lens. In addition to
the spectroscopic observations, biochemical basis is put
forth to explain the accumulation of AGE-like fluoro-
phore in processed lens samples, which significantly con-
tribute to the absorption of blue light and thereby
appearing yellow in aging lenses.
Conclusion
The present experimental study clearly indicates that
changes in AGE-like fluorophore in lens increases along
the age and with major changes commencing from the age
of 40–50 years onwards. This is a significant observation
with respect to Indian human lenses as it may lead to early
onset of senile cataract.
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